Understanding Rare Myocarditis Cases After mRNA COVID-19 Vaccination: New Insights from Science

The Role of mRNA Vaccines

The mRNA COVID-19 vaccines, including Pfizer-BioNTech COVID-19 Vaccine and Moderna COVID-19 Vaccine, were widely used during the global pandemic and played a major role in reducing severe illness and hospitalizations caused by COVID-19.

Following their rollout, surveillance systems in multiple countries detected a small number of myocarditis cases, particularly in younger males after the second dose. This led to extensive investigation by health agencies and independent researchers.

What Scientists Have Learned So Far

Health authorities such as the World Health Organization and national regulatory agencies have reviewed large datasets from millions of vaccinated individuals. Their conclusions have remained consistent: myocarditis after mRNA vaccination is rare.

Key findings from ongoing studies include: